Alloanti‐Hy in antenatal patients: A multi‐case review.

Introduction: Introduction The Hy antigen is one of ten red cell antigens belonging to the Dombrock blood group system, with an antigen frequency of almost 100% in the majority of populations. Alloantibodies to high prevalence antigens cause difficulties with antibody identification and exclusion in serological investigations. Case Presentation: This review describes the management of four antenatal cases where the presence of alloanti‐Hy had been identified. Hy‐red blood cell units may be required for the transfusion of patients with alloanti‐Hy, but currently, there are no published reports of alloanti‐Hy causing haemolytic disease of the fetus and newborn (HDFN). A previous case report involving the care and management of antenatal patients with alloanti‐Hy antibodies indicates a lack of evidence that alloanti‐Hy causes clinical HDFN. Results: All cases discussed in this review demonstrate a reduction in the strength of alloanti‐Hy levels as pregnancy progressed. Signs or symptoms of HDFN were not observed with any of the pregnancies. Conclusion: Factors such as antibody levels, antigenic expression, and varying clinical responses enhance our understanding of why alloanti‐Hy has not been known to cause clinical HDFN. The cases presented here aim to improve understanding of alloanti‐Hy in pregnancy and how to manage such cases. [ABSTRACT FROM AUTHOR]